[go: up one dir, main page]

WO2007117419A3 - Procédés et compositions associés à des inhibiteurs d'une enzyme de clivage post-prolyle - Google Patents

Procédés et compositions associés à des inhibiteurs d'une enzyme de clivage post-prolyle Download PDF

Info

Publication number
WO2007117419A3
WO2007117419A3 PCT/US2007/008242 US2007008242W WO2007117419A3 WO 2007117419 A3 WO2007117419 A3 WO 2007117419A3 US 2007008242 W US2007008242 W US 2007008242W WO 2007117419 A3 WO2007117419 A3 WO 2007117419A3
Authority
WO
WIPO (PCT)
Prior art keywords
post
enzyme inhibitors
methods
cleaving enzyme
compositions relating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2007/008242
Other languages
English (en)
Other versions
WO2007117419A8 (fr
WO2007117419A2 (fr
Inventor
Sharlene Adams
Michael I Jesson
Glenn T Miller
Paul A Mclean
Barry Jones
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Point Therapeutics Inc
Original Assignee
Point Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Point Therapeutics Inc filed Critical Point Therapeutics Inc
Publication of WO2007117419A2 publication Critical patent/WO2007117419A2/fr
Publication of WO2007117419A8 publication Critical patent/WO2007117419A8/fr
Publication of WO2007117419A3 publication Critical patent/WO2007117419A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/69—Boron compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

L'invention concerne l'utilisation d'inhibiteurs d'une enzyme de clivage post-prolyle dans le traitement de troubles prolifératifs tels que le cancer.
PCT/US2007/008242 2006-03-31 2007-03-30 Procédés et compositions associés à des inhibiteurs d'une enzyme de clivage post-prolyle Ceased WO2007117419A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US78782006P 2006-03-31 2006-03-31
US60/787,820 2006-03-31

Publications (3)

Publication Number Publication Date
WO2007117419A2 WO2007117419A2 (fr) 2007-10-18
WO2007117419A8 WO2007117419A8 (fr) 2008-02-14
WO2007117419A3 true WO2007117419A3 (fr) 2008-07-10

Family

ID=38581565

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2007/008242 Ceased WO2007117419A2 (fr) 2006-03-31 2007-03-30 Procédés et compositions associés à des inhibiteurs d'une enzyme de clivage post-prolyle

Country Status (1)

Country Link
WO (1) WO2007117419A2 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105412113B (zh) * 2015-11-05 2018-01-09 中国科学院武汉病毒研究所 培美曲塞二钠或其药学上可接受的盐在制备治疗或预防疱疹病毒感染药物中的应用
CN105326841B (zh) * 2015-11-05 2018-01-09 中国科学院武汉病毒研究所 雷替曲塞或其药学上可接受的盐在制备治疗或预防疱疹病毒感染药物中的应用
KR102557900B1 (ko) 2016-09-07 2023-07-19 트러스티즈 오브 터프츠 칼리지 면역-dash 억제제와 pge2 길항제를 이용한 병행 요법
CN110035766B9 (zh) * 2016-09-21 2023-12-15 新加坡科技研究局 用于抑制皮肤炎症和确定癌症易感性的方法和组合物
CN107970442A (zh) * 2017-12-06 2018-05-01 成都康华生物制品有限公司 一种吸附无细胞百白破和b型嗜血流感四价联合疫苗的制备方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6875737B1 (en) * 1996-06-28 2005-04-05 Trustees Of Tufts College Multivalent compounds for crosslinking receptors and uses thereof
US6890904B1 (en) * 1999-05-25 2005-05-10 Point Therapeutics, Inc. Anti-tumor agents
US7109347B2 (en) * 2001-06-27 2006-09-19 Probiodrug Ag Dipeptidyl peptidase IV inhibitors and their uses as anti-cancer agents

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6875737B1 (en) * 1996-06-28 2005-04-05 Trustees Of Tufts College Multivalent compounds for crosslinking receptors and uses thereof
US6890904B1 (en) * 1999-05-25 2005-05-10 Point Therapeutics, Inc. Anti-tumor agents
US7109347B2 (en) * 2001-06-27 2006-09-19 Probiodrug Ag Dipeptidyl peptidase IV inhibitors and their uses as anti-cancer agents

Also Published As

Publication number Publication date
WO2007117419A8 (fr) 2008-02-14
WO2007117419A2 (fr) 2007-10-18

Similar Documents

Publication Publication Date Title
WO2008076278A8 (fr) Procédés de traitements
WO2009099719A3 (fr) Compositions et procédés de traitement d'une tumeur d'origine hématopoïétique
WO2008030883A3 (fr) Traitement du cancer
WO2008124660A3 (fr) Procédés et compositions pour le traitement du cancer
WO2006071960A3 (fr) Compositions et procedes de traitement de troubles de la proliferation cellulaire
WO2007011962A3 (fr) Traitement du cancer
WO2010074588A8 (fr) Composés pharmaceutiques
WO2008128072A3 (fr) Inhibiteurs de la kinase axl
WO2008127290A3 (fr) Compositions d'alginate et d'alginate-lyase et procédés d'utilisation
WO2010002956A3 (fr) Dérivés hétérocycliques en tant que modulateurs des canaux ioniques
WO2008014238A3 (fr) Inhibiteurs des iap dimères
WO2007089445A3 (fr) Combinaisons d'inhibiteurs d'ang2 et de vegf
WO2007092622A3 (fr) Compositions et méthodes pour le traitement d'os
WO2009006577A3 (fr) Compositions et méthodes pour inhiber la protéine ezh2
WO2007145704A3 (fr) Thérapie de combinaison de gemcitabine
WO2008086462A3 (fr) Dérivés de quinalozine substitués par amino en tant qu'inhibiteurs de la voie b-caténine/tcf-4 et agents de traitement du cancer
WO2007127204A3 (fr) Méthodes et compositions concernant une immunostimulation
WO2008014229A3 (fr) Inhibiteurs des iap dimères
WO2007140205A3 (fr) Procédés de traitement de fibrose
WO2009064752A3 (fr) Dérivés hétérocycliques utilisés comme modulateurs des canaux ioniques
WO2007081751A9 (fr) Compositions et procedes destines au traitement du cancer
WO2009010787A3 (fr) Compositions stables
WO2009009034A3 (fr) Procédées et compositions utiles dans le traitement de la mucosite
WO2008092099A3 (fr) Compositions et procédés de traitement de malignités hématopoïétiques
AU2007260950A8 (en) Methods and compositions for targeting HEPSIN

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07754725

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 07754725

Country of ref document: EP

Kind code of ref document: A2